Skip to main content
. Author manuscript; available in PMC: 2017 Apr 7.
Published in final edited form as: J Vasc Interv Radiol. 2011 Apr 8;22(6):857–864. doi: 10.1016/j.jvir.2011.01.458

Table 5.

Treatment Outcomes at 12 Months Based on T2-weighted Imaging Appearance

Group No. of Pts.* Overall Symptom Relief
Improved No Change Additional Procedures
Dark
 Minimal heterogeneity 48 43 (90) 2 (4) 3 (6)
 Substantial heterogeneity 33 29 (88) 4 (12)
Isointense 4 4 (100)
Bright 4 2 (50) 1 (25) 1 (25)

Note.—Differences are not statistically significant. Values in parentheses are percentages.

*

Among 89 patients who provided relief information at 12-month interview.